Skip to main content

Consolidated Cash Flow Statement

for the period from October 1 to September 30 (IFRS)

in € thousand12 months 2020/2112 months
Earnings before taxes825,295367,323
Depreciation and amortization of fixed assets (including impairment losses or their reversals)212,574209,653
Change in allowances on receivables and other assets6461,261
Change in non-current provisions8,4321,200
Net gains/losses on disposal of fixed assets-7002,230
Measurement of derivatives49,76215,967
Other non-cash items2,0826,314
Expenses and income included in the financial result4,6078,269
Income taxes received/paid-88,081-64,099
Gross cash flow1,014,617548,118
Change in receivables and other assets-90,764-49,149
Change in inventories (including measurement effects)-397,417-344,988
Change in current provisions-8,55823,675
Change in liabilities (excluding financial liabilities)294,206281,283
Cash inflow from operating activities (net cash flow)812,084458,939
Payments for investments in fixed assets-252,444-229,955
Payments for the acquisition of shares in affiliated companies less cash acquired0-332,213
Payments from the granting of loans to related entities-10,855-5,359
Proceeds from the disposal of fixed assets1,845328
Proceeds from the disposal of business units12,3290
Proceeds from the redemption of loans granted to related entities8,2000
Interest received3,6136,679
Dividends received5,2574,888
Cash outflow from investing activities-232,055-555,631
Proceeds deriving from the take-up of financial liabilities26,275411,124
Payments for the redemption of bonds and financial liabilities-30,524-162,953
Acquisition of treasury shares-18,944-39,288
Interest paid-15,812-15,996
Dividends paid-56,946-56,386
Cash outflow (inflow in the previous year) from financing activities-95,951136,501
Net change in cash and cash equivalents484,07739,808
Changes resulting from movements in exchange rates146-205
Cash and cash equivalents at beginning of period481,064441,461
Cash and cash equivalents at end of period965,287481,064
Less cash and cash equivalents of assets held for sale at end of period-22,8520
Cash and cash equivalents at end of period (consolidated statement of financial position)942,435481,064